| | | | | | | | | | |
|
|
|
|
| Dockets Entered
On August 31, 2005
Table of Contents
|
|
|
|
|
|
|
|
|
|
|
| Docket #
|
| Title
|
|
|
|
|
|
|
| 1999N-4282
|
| Biotechnology in the Year 2000 and Beyond; Public Meetings
|
|
|
|
|
| 2001P-0075
|
| Switch Status of Emergency Contraceptives from Rx to OTC
|
|
|
|
|
| 2001P-0230
|
| Domestic Marketing & Importation of Transgenic Fish
|
|
|
|
|
| 2003P-0544
|
| Modify existing food additive regulation with respect to the irradiation of ground beef byproducts
|
|
|
|
|
| 2005D-0062
|
| Draft Guidance FDAs Drug Watch for Emerging Drug Safety
|
|
|
|
|
| 2005D-0155
|
| Guidance for Industry: Toxicity Grading Scale for Healthy Adult and Adolescent Volunteers Enrolled in Preventive Vaccine Clinical Trials
|
|
|
|
|
| 2005D-0174
|
| Guidance on Expiration Dating of Unit-Dose Repackaged Drugs
|
|
|
|
|
| 2005N-0149
|
| Animal Drugs, Feeds, and Related Products; Withdrawal of Approval of NADAs
|
|
|
|
|
| 2005N-0262
|
| Submission of Chemistry, Manufacturing, and Controls Information in a New Drug Application Under the New Pharmaceutical Quality Assessment System; Notice of Pilot Program
|
|
|
|
|
| 2005P-0267
|
| Remove from label for propofol (Diprivan) the warning that propofol should be administered only by trained persons
|
|
|
|
|
| 2005P-0351
|
| Losartan Potassium Oal Solution make a determination that it may be submitted for ANDA
|
|
|
|
|
| 2005V-0333
|
| Projector for a Laser Light Show
|
|
| |
|
| 1999N-4282
|
| Biotechnology in the Year 2000 and Beyond; Public Meetings
|
|
|
|
|
| C 18237
|
| A. Houston
|
| Vol #:
|
| 516
|
|
|
|
|
| C 18238
|
| T. Singleton
|
| Vol #:
|
| 516
|
|
| |
|
| 2001P-0075
|
| Switch Status of Emergency Contraceptives from Rx to OTC
|
|
|
|
|
| C 2093
|
| C. Connolly
|
| Vol #:
|
| 300
|
|
|
|
|
| C 2094
|
| S. Wharam
|
| Vol #:
|
| 300
|
|
|
|
|
| C 2095
|
| D. Waters
|
| Vol #:
|
| 300
|
|
|
|
|
| EMC 14489
|
| Form Letters
|
| Vol #:
|
| 344
|
|
|
|
|
| EMC 14490
|
| Form Letters
|
| Vol #:
|
| 345
|
|
|
|
|
| 2001P-0230
|
| Domestic Marketing & Importation of Transgenic Fish
|
|
|
|
|
| C 1359
|
| T. Singleton
|
| Vol #:
|
| 259
|
|
|
|
|
| 2003P-0544
|
| Modify existing food additive regulation with respect to the irradiation of ground beef byproducts
|
|
|
|
|
| C 42
|
| T. Singleton
|
| Vol #:
|
| 5
|
|
|
|
|
| 2005D-0062
|
| Draft Guidance FDAs Drug Watch for Emerging Drug Safety
|
|
|
| C 18
|
| R. Soller, PhD
|
| Vol #:
|
| 2
|
|
|
|
|
| 2005D-0155
|
| Guidance for Industry: Toxicity Grading Scale for Healthy Adult and Adolescent Volunteers Enrolled in Preventive Vaccine Clinical Trials
|
|
|
|
|
| C 7
|
| D. Diemert, MD
|
| Vol #:
|
| 1
|
|
|
|
|
| 2005D-0174
|
| Guidance on Expiration Dating of Unit-Dose Repackaged Drugs
|
|
|
|
|
| C
3
|
| Bristol-Myers Squibb Company (BMS)
|
| Vol #:
|
| 1
|
|
| | | | | | | | |
|
|
|
| 2005N-0149
|
| Animal Drugs, Feeds, and Related Products; Withdrawal of Approval of NADAs
|
|
|
|
|
| NWL
1
|
| FDA
|
| Vol #:
|
| 1
|
|
|
|
|
| 2005N-0262
|
| Submission of Chemistry, Manufacturing, and Controls Information in a New Drug Application Under the New Pharmaceutical Quality Assessment System; Notice of Pilot Program
|
|
|
|
|
| LET
3
|
| sanofi-aventis Group
|
| Vol #:
|
| 1
|
|
| |
|
| 2005P-0267
|
| Remove from label for propofol (Diprivan) the warning that propofol should be administered only by trained persons
|
|
|
|
|
| C 15
|
| D. Footerman, MD
|
| Vol #:
|
| 2
|
|
|
|
|
| C 16
|
| S. Levy, MD
|
| Vol #:
|
| 2
|
|
|
|
|
| C 17
|
| B. Greene, CRNA
|
| Vol #:
|
| 2
|
|
|
|
|
| C
18
|
| Advanced Anesthesia Specialists
|
| Vol #:
|
| 2
|
|
|
|
|
| 2005P-0351
|
| Losartan Potassium Oal Solution make a determination that it may be submitted for ANDA
|
|
|
|
|
| ACK
1
|
| HFA-305 to Morton Grove Pharmaceuticals, Inc.
|
| Vol #:
|
| 1
|
|
|
|
|
| 2005V-0333
|
| Projector for a Laser Light Show
|
|
|
|
|
| CR
1
|
| HFA-305 to Brilor LLC / Amika Nightclub
|
| Vol #:
|
| 1
|
|
